. . . . . . . . . . . . . . . . . . . . "a(SCHEM:\"Very Low Density Lipoprotein\") -> r(MGI:Vldlr)" . "kin(p(PFM:\"Prkc Family\")) -> (a(SCHEM:\"Very Low Density Lipoprotein\") -> r(MGI:Vldlr))" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "1.4" . "completely abolished by pretreatment of the cells with PD 98059, an inhibitor of MEK and GF 109203X, an inhibitor of PKC. These results demonstrated that the PKC/ERK1/2 cascade is the essential signaling pathway by which VLDL activates VLDL receptor mRNA expression." . . "Selventa" . . . . "2014-07-03T14:30:16.557+02:00"^^ . . .